《即日市评》北水重临港股吐 新经济股挫 诺辉健康飙
恒指连升七日(累涨1,971点或6.8%)後,今日受友邦(01299.HK)及美团(03690.HK)拖累下回吐。美股昨晚个别发展,投资者把资金从科技股转向其他股份,道指升0.3%,但纳指跌0.6%;美国白宫指中美关系以竞争为主,美商会称与华脱钩或损失千亿美元,执笔之时美汇指数升至90.75,美股股道指期货最新跌45点或0.14%,纳指期货最新跌0.5%。A股复市走个别,上证综指升0.6%收3,675、深证成指跌1.2%,内地创业板指数下滑2.7%,沪深两市成交额1.085万亿人民币。
恒指高开98点见31,183点後转跌,尾市曾跌514点一度低见30,570点,最终全日跌489点或1.6%,收30,595点;国指跌187点或1.5%,收12,041点;恒生科技指数跌353点或3.2%,收10,591点。北水重临,大市全日成交总额增至2,826.81亿元,沪、深港通南下交易录得净流入金额分别为36.8亿及113.13亿元人民币。
美团(03690.HK)股价下滑5.2%收428元,快手(01024.HK)股价跌5.2%,心动(02400.HK)急滑16.3%,而中移动(00941.HK)逆市升2%。
【恒指止连升 友邦美团挫】
金融股走个别,港交所(00388.HK)股价上升0.4%收565.5元,友邦(01299.HK)全日股价下挫近4%收101.4元。汇丰环球研究发表报告指友邦将於3月中公布全年业绩,预期新业务价值为28.3亿美元,按年跌32%,,年化保费收入为52.4亿美元,按年跌20%。
汇丰研究指,友邦股价已反映今年新业务价值强劲,维持「持有」评级,目标价94元。市场将聚焦公司新业务价值展望、新业务价值放慢的原因、未来中国内地经营牌照的范围及业务建设的进展、香港在岸和离岸市场发展、会否考虑增加印度合营的股权等。
【跌股千三只 诺辉健康飙】
港股今日市宽转弱,主板股票的升跌比率为14比34(上日为30比19),下跌股份1,374只(跌幅3.4%),恒指成份股今日14只股份上升,下跌股份35只,升跌比率为27比67(上日为56比40);大市今日录沽空334.72亿元,占可沽空股份成交2,391.21亿元的14%(上日为16.128%)。
诺辉健康-B(06606.HK)今日首日挂牌,股价高开1.85倍报76元,早段曾回顺至70元拒绝再下,尾市曾再抽升至85.9元,全日收84元,较上市价26.66元,高57.34元或2.15倍,成交6,631万股,涉资50.89亿元。不计手续费,每手500股,账面赚28,670元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.